Search & Analyze

Fineotex Chemical Ltd.

ChemicalsChemicals

www.fineotex.com BSE: 533333NSE: FCL

₹53.40BSE0.04%

16 Sep, 4:01 PM

₹53.40

₹6.19K Cr

50.56

6.65

15.50%

₹54.09

₹49.35

₹62.44

₹18.98

Customise metrics bar

Price Performance

Peer Comparison

Name
SOLAR IND SOLARINDS	18,920.00	85.97	1,71,207.18	0.06	666.37	88.98%	3,668.20	70.26%	38.16
PIDILITE PIDILITIND	1,544.95	59.37	1,57,257.32	1.39	883.51	30.29%	4,551.55	21.27%	32.38
SRF LIMITED SRF	2,484.90	34.07	73,658.60	0.36	758.87	75.53%	5,033.26	31.81%	14.21
FLUOROCHEM FLUOROCHEM	4,548.60	81.08	49,966.37	0.07	219.00	20.33%	1,588.00	23.97%	9.58
NAVIN FLUORI NAVINFLUOR	8,110.00	53.06	41,610.88	0.18	243.31	107.67%	1,045.08	44.07%	21.39
GODREJ IND GODREJIND	1,135.40	32.50	38,246.07	0.00	523.36	-27.85%	5,448.09	22.16%	10.64
DEEPAKNTR DEEPAKNTR	1,595.20	27.69	21,757.42	0.47	345.01	207.36%	2,577.60	36.39%	11.58
Fineotex Chemical Ltd. FCL	53.40	50.56	6,185.83	0.85	48.21	92.60%	376.63	174.77%	19.04

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	153.02	141.90	145.73	125.92	119.79	137.07	137.70	183.71	313.73	376.63
Expenses	114.73	106.65	109.34	91.63	98.50	111.88	106.68	148.88	270.04	317.48
	38.29	35.25	36.39	34.29	21.29	25.20	31.03	34.84	43.69	59.14
	25.02%	24.84%	24.97%	27.23%	17.77%	18.38%	22.53%	18.96%	13.93%	15.70%
	4.15	4.88	6.90	4.99	7.55	9.15	7.72	6.75	9.46	10.09
Interest	0.59	0.25	0.22	0.20	0.40	0.16	0.34	0.23	0.63	0.10
	1.85	2.25	2.37	2.59	2.01	2.69	3.01	3.33	4.40	4.39
	40.00	37.63	40.71	36.49	26.42	31.49	35.39	38.02	48.12	64.74
	23.81%	22.47%	21.22%	23.72%	23.80%	20.53%	26.32%	20.80%	8.99%	25.54%
	30.11	28.75	31.85	27.63	19.97	24.81	25.99	26.35	31.61	38.40
	2.72	2.56	2.78	2.38	1.74	2.17	2.27	0.23	0.27	0.33

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME :
	368.23	517.00	568.97	533.33	772.23
	368.23	517.00	568.97	533.33	772.23
EXPENDITURE :
Increase/Decrease in Stock	-1.07	-2.68	-5.35	-14.15	-13.11
Raw Material Consumed	223.53	328.66	340.23	326.66	516.82
Power & Fuel Cost	1.08	1.58	1.75	2.15	2.77
Employee Cost	13.58	18.38	21.16	24.32	40.35
Other Manufacturing Expenses	19.08	19.91	21.24	20.72	24.63
General and Administration Expenses	14.26	13.07	15.76	13.84	20.07
Selling and Distribution Expenses	21.91	18.84	18.62	25.47	29.23
Miscellaneous Expenses	4.66	6.65	7.17	7.10	21.27
	297.02	404.40	420.59	406.11	642.03
Operating Profit (Excl OI)	71.21	112.59	148.38	127.23	130.19
	5.52	7.30	16.54	24.31	37.63
	76.72	119.90	164.92	151.53	167.82
Interest	0.92	0.82	1.33	1.07	1.36
PBDT	75.80	119.08	163.59	150.46	166.46
	2.51	4.28	6.02	9.22	13.42
Profit Before Taxation & Exceptional Items	73.29	114.80	157.57	141.24	153.03
	73.29	114.80	157.57	141.24	153.03
Provision for Tax	16.40	25.24	36.54	32.04	28.02
	56.89	89.55	121.02	109.21	125.02
Extra items				0.00	0.00
Minority Interest	-1.72	-1.24	-1.22	-1.00	-16.26
Consolidated Net Profit	55.17	88.32	119.81	108.21	108.75
Profit Balance B/F	178.86	230.66	314.55	430.19	529.37
Appropriations	234.04	318.98	434.36	538.40	638.12
Equity Dividend %	20.00%	40.00%	80.00%	40.00%	45.00%
	4.98	7.97	10.82	9.44	0.93
Adjusted EPS	0.50	0.80	1.08	0.94	0.93

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	22.15	22.15	22.15	22.92	116.45
Share Warrants & Outstandings	0.04	0.28	0.48	0.81	0.34
Total Reserves	239.95	326.23	424.45	707.60	765.64
Reserve excluding Revaluation Reserve	239.95	326.23	424.45	707.60	765.64
Revaluation reserve			0.00	0.00
	262.15	348.66	447.09	731.32	882.43
Minority Interest	7.25	7.01	6.47	7.55	57.30
Unsecured Loans					3.82
Deferred Tax Assets / Liabilities	1.12	2.12	3.86	6.56	8.11
Other Long Term Liabilities	0.77	1.04	0.97	2.01	2.17
Long Term Provisions	0.14	0.03	0.35	0.09	0.09
Total Non-Current Liabilities	2.02	3.19	5.18	8.66	14.18
Trade Payables	58.77	47.36	72.81	56.75	160.93
Other Current Liabilities	7.17	8.84	10.94	9.76	36.48
Short Term Borrowings	1.88	7.28	5.19	0.22	4.38
Short Term Provisions	0.25	0.36	0.47	0.37	3.51
Total Current Liabilities	68.07	63.84	89.41	67.10	205.30
Total Liabilities	339.49	422.70	548.15	814.63	1,159.22
Gross Block	87.48	106.56	154.68	204.96	355.00
Less: Accumulated Depreciation	7.38	11.62	17.54	26.27	77.24
Net Block	80.10	94.94	137.13	178.69	277.76
Capital Work in Progress		0.36		21.08	2.18
Non Current Investments	17.31	89.33	107.95	330.40	290.43
Long Term Investment	17.31	89.33	107.95	330.40	290.43
Long Term Loans & Advances	6.19	8.85	12.97	21.43	11.39
Other Non Current Assets	0.15	1.35	0.32	2.10	2.35
Total Non-Current Assets	107.69	198.77	262.31	553.70	584.11
Currents Investments	0.00		38.76		27.05
Inventories	59.59	47.29	50.11	64.48	154.61
Sundry Debtors	110.89	101.40	138.82	115.86	290.29
Cash and Bank	38.06	59.57	39.92	41.70	46.18
Other Current Assets	2.00	3.14	3.67	4.25	3.78
Short Term Loans and Advances	14.06	5.32	7.36	27.44	46.00
Total Current Assets	224.60	216.73	278.64	253.73	567.90
Net Current Assets (Including Current Investments)	156.52	152.88	189.23	186.62	362.60
Total Assets	339.49	422.70	548.15	814.63	1,159.22
Contingent Liabilities	0.11	1.14	4.57	5.56	3.35
Total Debt	1.91	7.28	5.19	0.22	8.20
	23.67	31.46	40.32	63.76	7.57
Adjusted Book Value	2.37	3.15	4.03	6.38	7.57

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	73.29	114.80	157.57	141.24	153.03
Adjustment	-0.66	0.90	-7.55	-11.77	-2.74
Changes In working Capital	-42.16	17.93	-14.06	-31.73	-150.68
Cash Flow after changes in Working Capital	30.47	133.63	135.96	97.74	-0.39
Cash Flow from Operating Activities	13.38	107.27	97.04	69.33	-23.81
Cash Flow from Investing Activities	-0.74	-101.84	-46.49	-272.51	105.18
Cash Flow from Financing Activitie	-5.66	-6.44	-23.91	176.49	-62.52
Net Cash Inflow / Outflow	6.97	-1.01	26.65	-26.68	18.85
Opening Cash & Cash Equivalents	20.54	28.93	30.29	56.32	29.07
Effect of Foreign Exchange Fluctuations	1.41	2.37	-0.61	-0.56	8.19
Closing Cash & Cash Equivalent	28.93	30.29	56.32	29.07	56.12

Ratios

Valuation

50.56

6.65

30.33

6.11

1.05

7.99

Profitability

15.50

19.04

12.67

16.86

16.19

Leverage & Liquidity

0.01

2.77

113.37

Returns

0.85

0.78

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26
	64.46	62.88	62.86	62.88	62.88	62.88	62.57	62.30	62.30
	4.61	6.91	6.97	6.55	5.68	3.97	3.80	4.19	4.52
	30.94	30.21	30.17	30.58	31.44	33.14	33.63	33.50	33.18
	35.54	37.12	37.14	37.12	37.12	37.12	37.43	37.70	37.70
No. of Shareholders	1,26,673	1,28,268	1,29,068	1,33,899	1,36,842	1,46,522	1,64,466	1,62,276	1,80,711

Corporate Actions

Showing: All

Date	Type	Details
2026-08-18	AGM
2026-08-11	Board Meeting	Fund raising & A.G.M.
2026-07-16	Board Meeting	Quarterly Results

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

ChemicalsChemicals

Fineotex Chemical Ltd. operates in the Chemicals sector under the Chemicals industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

8 members across the board and senior leadership

Sunny Parmar

Company Secretary & Compliance Officer

—

Surendra Kumar Tibrewala

Chairman & Managing Director

₹1.29 Cr

Mar '26

Sanjay Tibrewala

Whole Time Director

₹1.29 Cr

Mar '26

Aarti Jhunjhunwala

Executive Director

₹1.17 Cr

Mar '26

Amit Prabhakar Pratap

Non Executive Independent Director

₹60,000

Mar '26

Bindu Shah

Non Executive Independent Director

₹95,000

Mar '26

Chetan Shah

Non Executive Independent Director

₹80,000

Mar '26

Sunil Vasant Waghmare

Non Executive Independent Director

₹95,000

Mar '26

FCL Latest News

News

5 of 5 articles

COMPANY2 Sept 2026 · 15:49

Fineotex Chemical’s arm incorporates wholly-owned step-down subsidiary in USA

Fineotex Biotex HealthGuard FZE has incorporated a new wholly-owned step-down subsidiary named Fineotex Holdings Inc.

EQUITY30 Jun 2026 · 16:33

Fineotex Chemical informs about newspaper publication

COMPANY8 Jun 2026 · 16:30

Fineotex Chemical’s arm expands Texas capacity by 150 MM lbs/year

The expansion has enhanced the company's ability to meet the growing demand for specialty chemicals across domestic and international markets

EQUITY8 Jun 2026 · 15:29

Fineotex Chemical informs about press release

EQUITY15 May 2026 · 20:36

Fineotex Chemical reports Profit after tax of Rs 211.35 Mln, in the March 2026 quarter

FCL

₹53.40

-0.04%